Dermata Therapeutics, Inc.
DRMA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4,664 | $6,481 | $9,719 | $3,162 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $2 | $13 |
| Total Curr. Assets | $5,071 | $6,481 | $10,005 | $3,534 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $160 | $0 | $0 |
| Total Assets | $5,071 | $6,641 | $10,005 | $3,534 |
| Liabilities | – | – | – | – |
| Payables | $453 | $414 | $1,395 | $808 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | -$0 | -$122 | -$0 | $0 |
| Total Curr. Liab. | $1,111 | $414 | $2,704 | $1,973 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $613 | $0 | $0 |
| Total NC Liab. | $0 | $613 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,111 | $1,026 | $2,704 | $1,973 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $1 | $0 |
| Retained Earnings | -$71,372 | -$69,680 | -$67,979 | -$65,675 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | -$0 | $0 | $0 | $0 |
| Total Equity | $3,960 | $5,614 | $7,301 | $1,561 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $5,071 | $6,641 | $10,005 | $3,534 |
| Net Debt | -$4,664 | -$6,481 | -$9,719 | -$3,162 |